# Autologous BMNC Infusion for Liver Cirrhosis in Children With BA

> **NCT05517317** · PHASE1 · COMPLETED · sponsor: **Vinmec Research Institute of Stem Cell and Gene Technology** · enrollment: 12 (actual)

## Conditions studied

- Biliary Atresia

## Interventions

- **COMBINATION_PRODUCT:** Autologous BMMC transplantation

## Key facts

- **NCT ID:** NCT05517317
- **Lead sponsor:** Vinmec Research Institute of Stem Cell and Gene Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2022-05-30
- **Final completion:** 2022-05-30
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05517317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05517317, "Autologous BMNC Infusion for Liver Cirrhosis in Children With BA". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05517317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*